BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
Recombinant Bifidobacterium longum 1,3-β-galactosyl-N-acetylhexosamine phosphorylase 112A produced by Escherichia coli, is classified with the enzyme commission (E.C.) number 2.4.1.211 and functions as a β-D-galactopyranosyl-1,3-N-acetyl-D-glucosamine phosphorylase.
Expression System
Escherichia coli
Species
Bifidobacterium longum
Concentration
1 mg/mL
Form
Liquid
Purity
≥90%, determined by SDS-PAGE.
Activity
Galactosyl-N-acetylhexosamine phosphorylases
Buffer
35 mM NaHepes buffer (pH 7.5), 750 mM NaCl, 200 mM imidazole, 3.5 mM CaCl2, and 25% (v/v) glycerol
Applications
Recombinant Bifidobacterium longum 1,3-β-galactosyl-N-acetylhexosamine phosphorylase 112A can be used for glycobiology research. It has the ability to hydrolyze N-acetylglucosamine (GlcNAc) oligomers.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.